HHS Cancels Millions in Pandemic Influenza mRNA Vaccine Development Grants

by | May 30, 2025 | Myeloma News | 0 comments

Source: Pharmacy Times articles

The announcement is set to affect multiple grants awarded to Moderna, which is developing mRNA-1018, a candidate vaccine against avian influenza.
Read More

Submit a Comment